Part 1: Dr. Riordan discusses mesenchymal stem cell sources from umbilical cord Wharton’s jelly, stem cell expansion, therapeutic potential of umbilical cord mesenchymal stem cells vs. bone marrow mesenchymal stem cells, CD34+ hematopoietic stem cells from umbilical cord blood and the scientific rationale supporting stem cell treatment of spinal cord injury.
Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 1 of 5)
Reviewed By:
Carolyn De La Guardia, M.D.
Staff Physician
Earning her medical degree from Universidad Latina de Panamá and specializing in clinical medicine, Dr. De La Guardia believes stem cell therapy is the future of medicine. She previously practiced in Panama’s public health system before joining Stem Cell Institute.